AiCuris Anti-infective Cures GmbH
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AiCuris Anti-infective Cures GmbH
European COVID-19 Project An ‘Unprecedented’ Exercise In Cooperation
Repurposed drugs, new compounds and neutralizing antibodies are among the targets of a new collaborative venture supported by Europe’s Innovative Medicines Initiative.
Coronavirus Update: Sanofi and GSK ‘Happy To Lose’ COVID-19 Vaccine Race
Heads of vaccines development at partners GSK and Sanofi:“This is not a sprint, it’s a marathon.”
Royalty Pharma Nears Biopharma Record Take With $2.18bn IPO
Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.
Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo
Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.
- Drug Discovery Tools
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.